Features
Individualizing Glaucoma Medical Management
Physician self-awareness and understanding of patients’ psychosocial factors can improve adherence to glaucoma therapy.
By Robert M. Kinast, MD
Integrating a Digital Microscope With Intraoperative OCT
Transition from flying blind to informed glaucoma surgery.
By Steven D. Vold, MD
New Options in Minimally Invasive Glaucoma Surgery
Glaucoma surgeons describe new devices and the learning curve to implement them.
By Mark J. Gallardo, MD, Matt Porter, MD
Current Choices in Glaucoma Drainage Devices
Tube shunts remain a mainstay in glaucoma treatment.
By Michael J. Pro, MD
Developing a Direct Selective Laser Trabeculoplasty System
Glaucoma Physician speaks with Prof. Michael Belkin.
By Jennifer Ford, content director
Web Exclusives
Glaucoma-related Malpractice Litigation
The best protection is thorough documentation.
By Nikki A. Mehran, MS, Natasha Nayak Kolomeyer, MD,
Departments
From the Editor: The Value of Quality Glaucoma Care
By Nathan Radcliffe, MD
Coding: Interpretation and Report of Diagnostic Testing
Understand what elements are required.
By Brandy H. Sperry, COMT, COE, CPC, CPMA, Kevin J. Corcoran, COE, FNAO
Patients Are Asking: Is My Eye Pressure Related to My Blood Pressure?
Take advantage of this teaching opportunity.
By Paul Petrakos, DO
Case Files: Cataract Surgery in the Refractive-minded Patient
Manage more than glaucoma.
By Brandon Baartman, MD
News
Proposed Medicare Physician Fee Schedule for MIGS Called Disappointing
By Jerry Helzner, contributing editor
Vyzulta Effective as Adjunct Glaucoma Medication
By Jerry Helzner, contributing editor
AAO Adopts New Prior Authorization Recommendations
By Jerry Helzner, contributing editor
Wide Gender Pay Gap in Year 1 of Clinical Practice
By Jerry Helzner, contributing editor
Hormonal Contraceptives Carry Glaucoma Risk
By Jerry Helzner, contributing editor
Home Tonometry Tracks Intraday IOP Changes
By Jerry Helzner, contributing editor
FDA Approves CATS Disposable Tonometer Prism
By Jerry Helzner, contributing editor
Xen Stent Effective and Safe at 3 Years
By Jerry Helzner, contributing editor
iStar Medical to Begin Pivotal MIGS Trial
By Jerry Helzner, contributing editor